191 related articles for article (PubMed ID: 12796588)
41. The cyclin-dependent kinase inhibitor, p27, has no correlation with the malignant potential of GIST.
Shirin H; Kravtsov V; Shahmurov M; Shabat VS; Krinshpon I; Alin A; Avinoach I; Avni Y
Digestion; 2007; 75(1):4-9. PubMed ID: 17406118
[TBL] [Abstract][Full Text] [Related]
42. Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study.
Sökmensüer C; Gedikoglu G; Uzunalimoglu B
Hepatogastroenterology; 2001; 48(39):720-3. PubMed ID: 11462912
[TBL] [Abstract][Full Text] [Related]
43. Immunohistochemistry and c-kit gene analysis in determining malignancy in gastrointestinal stromal tumors.
Yamaguchi M; Tate G; Endo Y; Miyaki M
Hepatogastroenterology; 2003; 50(53):1431-5. PubMed ID: 14571755
[TBL] [Abstract][Full Text] [Related]
44. Are there any prognostic factors for small intestinal stromal tumors?
Bucher P; Taylor S; Villiger P; Morel P; Brundler MA
Am J Surg; 2004 Jun; 187(6):761-6. PubMed ID: 15191872
[TBL] [Abstract][Full Text] [Related]
45. The significance of CD44 expression in gastrointestinal neuroendocrine tumors.
Lai CH; Shan YS; Sy ED; Hsieh YH; Tsai HW; Lee JC; Lin PW
Hepatogastroenterology; 2005; 52(64):1071-6. PubMed ID: 16001632
[TBL] [Abstract][Full Text] [Related]
46. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
47. Trends in incidence and survival of mesenchymal neoplasm of the digestive tract within a defined population of northern Norway.
Steigen SE; Eide TJ
APMIS; 2006 Mar; 114(3):192-200. PubMed ID: 16643186
[TBL] [Abstract][Full Text] [Related]
48. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.
Hassan I; You YN; Shyyan R; Dozois EJ; Smyrk TC; Okuno SH; Schleck CD; Hodge DO; Donohue JH
Ann Surg Oncol; 2008 Jan; 15(1):52-9. PubMed ID: 18000711
[TBL] [Abstract][Full Text] [Related]
49. Expression of alpha6 integrin subunit is associated with malignancy in gastric gastrointestinal stromal tumors.
Takeyama H; Funahashi H; Sawai H; Takahashi H; Yamamotorm M; Akamo Y; Manabe T
Med Sci Monit; 2007 Feb; 13(2):CR51-6. PubMed ID: 17261983
[TBL] [Abstract][Full Text] [Related]
50. [Prognostic factors of gastrointestinal stromal tumors of the stomach].
Hillemanns M; Päsold S; Böttcher K; Höfler H
Verh Dtsch Ges Pathol; 1998; 82():261-6. PubMed ID: 10095444
[TBL] [Abstract][Full Text] [Related]
51. An audit of surgical management of gastrointestinal stromal tumours (GIST).
Bucher P; Egger JF; Gervaz P; Ris F; Weintraub D; Villiger P; Buhler LH; Morel P
Eur J Surg Oncol; 2006 Apr; 32(3):310-4. PubMed ID: 16414236
[TBL] [Abstract][Full Text] [Related]
52. Comparative analysis of prognostic indicators for sarcomas of the soft parts and the viscerae.
Rudolph P; Bonichon F; Gloeckner K; Collin F; Chassevent A; Schmidt D; Coindre JM; Parwaresch R; Klöppel G
Verh Dtsch Ges Pathol; 1998; 82():246-52. PubMed ID: 10095442
[TBL] [Abstract][Full Text] [Related]
53. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico.
Alvarado-Cabrero I; Vázquez G; Sierra Santiesteban FI; Hernández-Hernández DM; Pompa AZ
Ann Diagn Pathol; 2007 Feb; 11(1):39-45. PubMed ID: 17240306
[TBL] [Abstract][Full Text] [Related]
54. Clinical implications of C-kit gene mutation in patients with large gastrointestinal stromal tumors.
Lin SC; Liu CL; Wang TI; Chang WS; Tzen CY; Huang MJ
J Gastroenterol Hepatol; 2006 Oct; 21(10):1604-8. PubMed ID: 16928224
[TBL] [Abstract][Full Text] [Related]
55. [Meta-analytical study of gastrointestinal stromal tumors (GIST)].
Liberati G; Lucchetta MC; Petraccia L; Nocchi S; Rosentzwig R; De Matteis A; Grassi M
Clin Ter; 2003; 154(2):85-91. PubMed ID: 12856366
[TBL] [Abstract][Full Text] [Related]
56. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.
Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437
[TBL] [Abstract][Full Text] [Related]
57. [Gastrointestinal stromal tumors: prognostic value of DNA analysis with flow cytometry and of classical clinicopathologic parameters].
Tarroch X; Salas A; Olona M; Moragas A
Med Clin (Barc); 1999 Jun; 112(20):761-6. PubMed ID: 10422056
[TBL] [Abstract][Full Text] [Related]
58. [Histopathological and cytological findings in a case of gastrointestinal stromal tumor presenting in the pelvic cavity].
Takekawa Y; Kimura M; Sakakibara M; Yoshii R; Yamashita Y
Rinsho Byori; 2007 Jun; 55(6):535-9. PubMed ID: 17657986
[TBL] [Abstract][Full Text] [Related]
59. Plexiform fibromyxoma: a distinctive benign gastric antral neoplasm not to be confused with a myxoid GIST.
Miettinen M; Makhlouf HR; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Nov; 33(11):1624-32. PubMed ID: 19675452
[TBL] [Abstract][Full Text] [Related]
60. Revision of gastrointestinal mesenchymal tumours with CD117.
de Schipper JP; Liem RS; van den Ingh HF; van der Harst E
Eur J Surg Oncol; 2004 Nov; 30(9):959-62. PubMed ID: 15498641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]